GOLEXANOLONE EXHIBITS LITTLE GENDER DIFFERENCE IN PHARMACOKINETICS AND IS WELL TOLERATED BY PATIENTS WITH CIRRHOSIS AT PLASMA LEVELS SHOWN TO MITIGATE THE CNS EFFECTS OF ALLOPREGNANOLONE.Jan Erik Berglund,Fredrik Rorsman,Igor Zupanets,Markku Partinen,Poul Jennum,Geza Lakner, Pontus Wasling,Hannes Hagstrom,Stergios Kechagias, Salla Lamusuo, Carin Ocklind,Eva Arlander,Torbjorn Backstrom,Magnus Doverskog,Maja Johansson,Maria Mansson,Per Samuelson,Martin Schalling, Agneta Wennerholm, Bruce F. ScharschmidtHEPATOLOGY（2019）引用 23|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
